Sep 22, 2026 10 0
Uploaded by Patrick
Favorite
Share
More Options
17
Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasms_Page 1

Open in WPS to view all 17 pages